Synthesis and Characterization of Novel Gold(I) Complex
[Triphenylphosphine-1,3-diethylbenzylimidazol-2-ylidene)]gold(I) iodide (MC4) was synthesized as described19 (link),20 (link),52 (link). TCDD was purchased from Sigma Aldrich (Germany). Resveratrol and Auranofin were from Santa Cruz (Germany). Antibodies of AHR (Biomol, Germany, AP5533C, 1:1000) and CYP1A1 were obtained from Abgent (Biomol, Germany, F50940, 1:1000). ACTIN (SC-47778, 1:1000) and VINCULIN (SC-73614) were from Santa Cruz. SMAD4 (9515, 1:1000), pSMAD3 (9520), and SMAD3 (9523, 1:1000) were from Cell Signaling (NEB, Germany).
Corresponding Organization : Heidelberg University
Other organizations :
University Hospital Heidelberg, Technische Universität Braunschweig, DKFZ-ZMBH Alliance, Ministero della Salute, German Center for Infection Research
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
